A non-interventional study to investigate triggers in psoriasis.
About this study
Psoriasis is a skin condition characterised by patches of skin that are typically red, itchy and scaly.
This study aims to understand the underlying mechanisms that trigger psoriasis and involves a one off-visit to clinics.
The outcome of this project and knowledge gained will potentially support the development of new treatments for psoriasis and psoriatic arthritis.
Anticipated enrolment close date: Ongoing
Contact Dermatology Research for more information.
Who can take part
- Above 18 years of age, with mild, moderate or severe psoriasis
- The presence of at least one psoriatic patch of at least 6mm in size
- No use of topical anti-psoriasis medications (except moisturisers) within two weeks on the patch to be biopsied
- No history of blood or lymphatic disorders
- No participation in any clinical study within three months before the visit date, provided that the clinical study did not entail a medication with a longer half-life
- One-off visit
- Biopsy samples of two psoriatic patches as well as from non-affected skin
- Blood samples
- Mouth swab for genetic testing
All research in Australia involving human participants is reviewed by an independent group called a Human Research Ethics Committee (HREC). The ethical aspects of this research study have been approved by the Royal Melbourne Hospital HREC.
This study is being carried out according to the National Statement on Ethical Conduct in Human Research (2007). This statement protects the interests of people who agree to participate in human research studies.
The Clinical Trials Centre (CTC) is a dedicated, purpose-built space where we conduct clinical trials.
The CTC is located on Level 2 South. When you arrive, if you are unsure where to go, talk to one of our friendly volunteers or the information desk staff.